• SPX
  • $5,751.07
  • 0.9 %
  • $51.13
  • DJI
  • $42,352.75
  • 0.81 %
  • $341.16
  • N225
  • $38,635.62
  • 0.22 %
  • $83.56
  • FTSE
  • $8,280.63
  • -0.02 %
  • -$1.89
  • IXIC
  • $18,137.85
  • 1.22 %
  • $219.38
KalVista Pharmaceuticals, Inc. (KALV) Latest News

KalVista Pharmaceuticals, Inc. (KALV) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price

$11.35

-$0.19

(-1.65%)

Day's range
$11.18
Day's range
$11.82

Latest News of KALV

Ipswich agree season-long loan deal for Kalvin Phillips from Manchester City

By The Guardian | 1 month ago

England midfielder Kalvin Phillips is set to undergo a medical with Ipswich on Thursday for a season-long loan from Manchester City. The move aims to revive his career after a disappointing stint at C...

The Briefing: Man City 4 Chelsea 2 -- Is there a way back for Kalvin Phillips? Can Oscar Bobb take his chance?

By The New York Times | 2 months ago

Manchester City concluded their U.S. tour with a 4-2 victory over Chelsea, led by Erling Haaland's early goals. Guardiola emphasizes team preparedness. Oscar Bobb's performance is praised. Analysis on...

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.